Lersivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.
Specification: ≥98%
Molecular Formula: C17H18N4O2
Molecular Weight: 310.35
PubChem CID: 16739244
Isomeric SMILES: CCC1=C(C(=NN1CCO)CC)OC2=CC(=CC(=C2)C#N)C#N
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/L125187-SCI_aabf3e7b57f1418a2e3fa3fc91fdf758.pdf
- UPC:
- 41113002
- Condition:
- New
- HazmatClass:
- Yes
- WeightUOM:
- LB
- MPN:
- L125187-100mg
- CAS:
- 473921-12-9
- Health Hazards:
- Carcinogen
- Product Size:
- 100mg
- Hazard Statement Codes:
- H361:H412:H373
- Precautionary Statement Codes:
- P501:P405:P280:P273:P260
akash.verma@cenmed.com
(732) 447-1115





